TRACK BRANDS ON AI
Monitor your brand, company, or product's online reputation in AI responses
Searching...
Loading...
It's taking longer than usual, we might be experiencing higher load.
Give it a few more seconds or try again in a moment.
Give it a few more seconds or try again in a moment.
Searching...
Loading...
What does AI know about Iovance Biotherapeutics Inc?
What does OpenAI free version (gpt-3.5-turbo) know about Iovance Biotherapeutics Inc?
| Last request | 10.12.2023
(There is a high chance that below response is an AI hallucination) |
| Well Known | No |
| Description | Iovance Biotherapeutics Inc is a biotechnology company focused on the development of novel cancer immunotherapies. |
| Most Notable Achievements | Iovance Biotherapeutics Inc has developed a novel T-cell therapy that has shown promising results in clinical trials. |
| The Most Negative Fact | Iovance Biotherapeutics Inc has yet to receive FDA approval for any of its products. |
| Competition | None |
| Share with friends |
Register your email below to unlock features!
Don't like the AI answers? Who can help me Change them?
What does OpenAI paid version (gpt-4) know about Iovance Biotherapeutics Inc?
| Request date | |
| Well Known | No |
| Description | Iovance Biotherapeutics Inc is a biotechnology company that focuses on developing and commercializing cancer immunotherapy products. |
| Most Notable Achievements | Their lead product candidate, LN-144, has shown promising results in clinical trials for the treatment of metastatic melanoma. |
| The Most Negative Fact | The company has faced challenges in scaling up production of their cell therapy products, which has led to delays in clinical trials. |
| Competition | None |
| Share with friends |
What does Google AI (PaLM) know about Iovance Biotherapeutics Inc?
| Last request | 07.01.2024 |
| Well Known | no |
| Description | Iovance Biotherapeutics Inc. is a clinical-stage biotechnology company focused on developing and commercializing cancer immunotherapy products. |
| Most Notable Achievements | The company's lead product candidate, Iovance's L-19, is a personalized cancer vaccine that is currently in Phase 3 clinical trials for the treatment of metastatic melanoma. |
| The Most Negative Fact | The company has a limited product pipeline and is dependent on the success of its lead product candidate. |
| Competition | None |
What does Microsoft Bing AI know about Iovance Biotherapeutics Inc?
| Well Known | No |
| Description | ehenvoihsttoeaos eeciv ci onmmheIoncl eatco.euv dehc en olrudnpe mynsay retBsbgon fa ntp i aotroofcpuopnc amieIcil |
| Most Notable Achievements | eo ondeaIg hne tehhcevcslsedauras ieylnscaloni imhcsooilws.ittrlar cn Bsrl apeTptiuctotl as hhla vIpvrnp -i aein et |
| The Most Negative Fact | ct u orh Fa eaenltcso r ssAtcntoea vI s.fy ft uooce vhraeaydcapoeonipriDppIeBi tvri |
| Competition | Nnoe |
Register your email below to unlock features!
Looks like you haven't registered an account yet?
Just search for a brand, person or top-list BELOW and register your email on the search results page:
